Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters. | Nucleic Acids Res | 2022 | 35390165 | PubTator, text mining | PubMed |
| In Silico Analysis of the Correlation of KIF2C with Prognosis and Immune Infiltration in Glioma. | Comput Math Methods Med | 2022 | 35387222 | PubTator, text mining | PubMed |
| Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma. | Front Genet | 2022 | 35386284 | PubTator, text mining | PubMed |
| SWAN pathway-network identification of common aneuploidy-based oncogenic drivers. | Nucleic Acids Res | 2022 | 35380699 | PubTator, text mining | PubMed |
| Aneuploidy tolerance caused by BRG1 loss allows chromosome gains and recovery of fitness. | Nat Commun | 2022 | 35365638 | PubTator, text mining | PubMed |
| MLL5 is involved in retinal photoreceptor maturation through facilitating CRX-mediated photoreceptor gene transactivation. | iScience | 2022 | 35359806 | PubTator, text mining | PubMed |
| Use of ATP-Binding Cassette Subfamily A Member 13 (ABCA13) for Sensitive Detection of Focal Pathological Forms of Subclinical Bovine Paratuberculosis. | Front Vet Sci | 2022 | 35359676 | PubTator, text mining | PubMed |
| Transcriptomics Reveals the Mevalonate and Cholesterol Pathways Blocking as Part of the Bacterial Cyclodipeptides Cytotoxic Effects in HeLa Cells of Human Cervix Adenocarcinoma. | Front Oncol | 2022 | 35359411 | PubTator, text mining | PubMed |
| Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib. | Cancer Biol Ther | 2022 | 35343367 | PubTator, text mining | PubMed |
| A Comprehensive View on the Quercetin Impact on Colorectal Cancer. | Molecules | 2022 | 35335239 | PubTator, text mining | PubMed |
| Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach. | Int J Mol Sci | 2022 | 35328380 | PubTator, text mining | PubMed |
| Rif1-Dependent Control of Replication Timing. | Genes (Basel) | 2022 | 35328102 | PubTator, text mining | PubMed |
| A Systematic Review to Define the Multi-Faceted Role of Lysine Methyltransferase SETD7 in Cancer. | Cancers (Basel) | 2022 | 35326563 | PubTator, text mining | PubMed |
| A Temporary Pause in the Replication Licensing Restriction Leads to Rereplication during Early Human Cell Differentiation. | Cells | 2022 | 35326512 | PubTator, text mining | PubMed |
| Identification of potentially functional circular RNAs hsa_circ_0070934 and hsa_circ_0004315 as prognostic factors of hepatocellular carcinoma by integrated bioinformatics analysis. | Sci Rep | 2022 | 35322101 | PubTator, text mining | PubMed |
| Construction and evaluation of a nomogram for predicting survival in patients with lung cancer. | Aging (Albany NY) | 2022 | 35321944 | PubTator, text mining | PubMed |
| Mobile origin-licensing factors confer resistance to conflicts with RNA polymerase. | Cell Rep | 2022 | 35320708 | PubTator, text mining | PubMed |
| Forkhead Box Transcription Factors: Double-Edged Swords in Cancer. | Cancer Res | 2022 | 35315926 | PubTator, text mining | PubMed |
| Candidate master microRNA regulator of arsenic-induced pancreatic beta cell impairment revealed by multi-omics analysis. | Arch Toxicol | 2022 | 35314868 | PubTator, text mining | PubMed |
| CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma. | Cell Death Dis | 2022 | 35304440 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=32